The largest database of trusted experimental protocols

16 protocols using ldn 193189

1

Directed Differentiation of Human PSCs

Check if the same lab product or an alternative is used in the 5 most similar protocols
Except where specified, reset cells were ʻre-primed' before initiating differentiation. Cells were plated on Geltrex in t2iLGö and after 48 h the medium was changed to E8. Cultures were maintained in E8, passaging at confluence. Lineage-specific differentiation was initiated between 25 and 44 days.
Definitive endoderm was induced according to Loh et al. (2014) (link). Cells were cultured in CDM2 medium (in-house according to Loh et al., 2014) supplemented with 100 ng/ml activin A (produced in-house), 100 nM PI-103 (Bio-Techne, 2930), 3 µM CHIR99021, 10 ng/ml FGF2, 3 ng/ml BMP4 (Peprotech) for 1 day. For the next 2 days the following supplements were applied: 100 ng/ml activin A, 100 nM PI-103, 20 ng/ml FGF2, 250 nM LDN193189.
For lateral mesoderm induction (Loh et al., 2016 (link)), cells were treated with CDM2 supplemented with 30 ng/ml activin A, 40 ng/ml BMP4 (Miltenyi Biotech, 130-098-788), 6 µM CHIR99021, 20 ng/ml FGF2, 100 nM PI-103 for 1 day, then with 1 µM A8301, 30 ng/ml BMP4 and 10 µM XAV939 (Sigma-Aldrich).
For neural differentiation via dual SMAD inhibition (Chambers et al., 2009 (link)), cells were treated with N2B27 medium supplemented with 500 nM LDN193189 (Axon, 1509) and 1 μM A 83-01 (Bio-Techne, 2939) for 10 days, then passaged to plates coated with poly-L-ornithine and laminin and further cultured in N2B27 without supplements.
+ Open protocol
+ Expand
2

Generation of Neural Progenitor Cells from H9 hESCs

Check if the same lab product or an alternative is used in the 5 most similar protocols
The H9 hESCs (WA09, purchased from the WiCell research Institute, female, RRID: CVCL_9773) colonies were maintained on matrigel‐coated 6‐well plates (Corning) in E8 flex medium [E8 basal medium (Gibco) supplemented with E8 supplement Flex and 5 U ml−1 Penicillin−Streptomycin]. The colonies were passaged twice a week (in 1:3 split ratio) using 0.5 mM EDTA (Gibco). To induce NPC, the hESCs were harvested into single‐cell suspensions by accutase (Sigma) and seeded at 2.5 million cells per well of 6‐well plate in the neural induction medium (NIM) consisting of neural maintenance medium (NMM) supplemented with the dual‐SMAD inhibitors SB431542 (10 µM, Tocris) and LDN193189 (1 µM, Miltenyi)[34 (link)
]. (For NMM preparation, see Supporting Information: Extended Description of Methods.) At day 10, the neuroepithelial cells were passaged three times with Dispase II (Sigma) in the NMM up to 34 days to further purify the NPC. The generated DIV (Day In Vitro) 34 NPC were stored in liquid nitrogen cell bank for subsequent experiments. To enable cell viability tracking, a genome‐engineered H9 hESCs line bearing the constitutive tdTomato reporter expression cassette in the Adeno‐Associated Virus Integration Site 1 (AAVS1) locus were used to generate NPC as described above. The use of hESCs was approved by the Human Ethics Committee at the University Hospital, Gasthuisberg, KU Leuven, Belgium.
+ Open protocol
+ Expand
3

Derivation and Differentiation of FUS-Mutant iPSCs

Check if the same lab product or an alternative is used in the 5 most similar protocols
Derivation and maintenance conditions of human iPSCs carrying the P525L mutation in both FUS alleles (FUSP525L, male) and their isogenic FUS wild-type control (FUSWT, male) used in this study are described in Lenzi et al. (2015) (link). The MN differentiation protocol is detailed in De Santis et al. (2017) (link) and depicted in Figure S1A. In brief, cells were differentiated in N2B27 medium supplemented with 1 mM all-trans retinoic acid (Sigma-Aldrich) and 1 mM SAG (Merck Millipore) for 12 days in the presence of 10 mM SB431542">SB431542 and 100 nM LDN-193189 (both from Miltenyi Biotec) from day 0 to 6, and 5 mM DAPT and 4 mM SU-5402 (both from Sigma-Aldrich) from day 6 to 12. Cells were sorted at day 12-13 using a FACSAria III (BD Biosciences) and re-plated on poly-L-ornithine- and laminin-coated dishes (both from Sigma-Aldrich) in Neural Medium as described in De Santis et al. (2017) (link).
+ Open protocol
+ Expand
4

Differentiation of iPSCs to Spinal Motor Neurons

Check if the same lab product or an alternative is used in the 5 most similar protocols
Wild-type BJ fibroblast-derived iPSCs (BJ-iPS) were cultured feeder-free on matrigel-coated plates in MACS iPS-Brew media (Miltenyi Biotec). Routine passaging using ReLeSR (Stem Cell Technologies) was performed once every 6-7 days. Pluripotent stem cells were differentiated towards the spinal motor neuron fate following established protocols described previously. Briefly, we first neutralized the BJ-iPS by activating Wnt pathways with CHIR99021 treatment (4.25 μM, Miltenyi Biotec) while blocking Bone Morphogenic Protein (BMP) signaling by LDN-193189 treatment (0.5 μM, Miltenyi Biotec) at the same time. At day 3, variable concentrations of retinoic acid and GDF11 were added to initiate the rostral-caudal patterning, in the presence of fixed concentration of Purmorphamine (1 μM, Miltenyi Biotec), a Sonic Hedgehog pathway agonist, as a ventralizing signal. Neurotrophic factors, BDNF (20 ng/ml, Miltenyi Biotec) and GDNF (20 ng/ml, Miltenyi Biotec), were added to the neuronal cultures at day 17 to promote neuronal maturation into motor neurons.
+ Open protocol
+ Expand
5

Differentiation of iPSCs into Melanocytes

Check if the same lab product or an alternative is used in the 5 most similar protocols
WT and HGPS iPSCs were grown in colonies on mouse embryonic fibroblasts (MEF), inactivated with 10 mg/ml mitomycin C seeded at 30,000 cells/cm², and grown as previously described. For differentiation, embryonic bodies (EBs) are formed from hESC and iPSC clumps and grown on low attachment dishes in neural medium composed of 1/2 neurobasal and 1/2 HAM:F12 complemented with 2% of B-27 without VitA (Invitrogen) and 1% N-2 (Invitrogen). Induction of neural-crest differentiation was realized using CHIR-99021 (TOCRIS), LDN-193189 (Miltenyi) and SB 431542 (TOCRIS). Melanogenic commitment was realized with CHIR99021(TOCRIS), EDN3 (American peptide), SCF (peprotech), BMP-4 (peprotech) and ascorbic acid (Sigma-Aldrich). At day 7, EBs were plated on gelatine 0.1% and grown in MGM-4 medium supplemented with the same cytokines until around day 30.
+ Open protocol
+ Expand
6

Differentiation of hiPSCs to Definitive Endoderm

Check if the same lab product or an alternative is used in the 5 most similar protocols
hiPSC were differentiated to definitive endoderm as per Ahmed et al. [45 ]. Briefly, 16 to 18 h before differentiation induction, cells were plated as single cells at 80000 cells/cm2 in 24- or 6-well plates in E8 medium supplemented with 10 μM Y-27632. Differentiation was induced by replacing the E8 medium with RPMI 1640 (GIBCO) supplemented with B27 without vitamin A (GIBCO), 100 ng/ml activin A (Peprotech), 3 mM CHIR-99021 (Tocris), and 10 μM Y-27632. After 24 h, the medium was changed to RPMI 1640 supplemented with B27 without vitamin A, 100 ng/ml activin A, and 250 nM LDN-193189 (Miltenyi biotec). Cells were then incubated for another 24 h to obtain definitive endoderm.
+ Open protocol
+ Expand
7

Differentiation of hiPS Cells into Progenitors

Check if the same lab product or an alternative is used in the 5 most similar protocols
hiPS cells were seeded onto flasks coated with Matrigel at a density of 0.5–1 × 104 cells per cm2 in primed hiPS cell medium (KSR/FGF2). After 24 h, medium was changed to DMEM/F12-based medium supplemented with ITS (insulin + transferrin + selenium; Sigma-Aldrich) with 1% penicillin and streptomycin (Gibco, ThermoFisher Scientific), 3 µM CHIR99021 (Miltenyi Biotec), 0.5 µM LDN193189 (Tocris Bioscience, Bio-Techne) for 3 days. On days 4–6, the medium was changed to DMEM/F12-based medium supplemented with ITS and 3 µM CHIR99021, 20 ng ml−1 FGF2 (Miltenyi Biotec), 0.5 µM LDN193189. On days 7–8, the medium was changed to DMEM/F12-based medium supplemented with 20 ng ml−1 FGF2, 0.5 µM LDN193189, 2 ng ml−1 IGF1 (Peprotech). On days 9–30, the medium was changed to DMEM/F12-based medium supplemented with 15% knockout serum replacement (Gibco, ThermoFisher Scientific), 1% penicillin and streptomycin, 0.05 mg ml−1 BSA (Sigma-Aldrich), 2 ng ml−1 IGF1.
+ Open protocol
+ Expand
8

Efficient Motoneuron Differentiation from hiPSCs

Check if the same lab product or an alternative is used in the 5 most similar protocols
Motoneurons were derived form ChR2-expressing transgenic hiPSC lines using a protocol adapted from Maury et al. [2 (link)]. Briefly, on day 0, 4×106 hiPSCs were transferred to petri dishes for suspension culture in 10ml of Motoneuron Suspension Culture Medium (MSCM, Table II). On day 0 MSCM was supplemented with 3 μM CHIR99021 (Tocris # 4423/10), 0.2 μM LDN193189 (Miltenyl Biotec #130–103-925), 40 μM SB431542 hydrate (Sigma Aldrich #S4317) and 5μM Y-27632 dihydrochloride. On day 2, neurospheres were isolated using 37 μm reversible strainers (STEMCELL Technologies #27215) and replated in MSCM supplemented with 3 μM CHIR99021, 0.2 μM LDN193189, 40 μM SB431542 hydrate, and 0.1 μM retinoic acid. Thereafter, media was replaced for MSCM supplemented with 0.5 μM SAG (Millpore #566660), 0.2 μM LDN193189, 40 μM SB431542, and 0.1 μM retinoic acid at day 4; 0.5 μM SAG and 0.1 μM retinoic acid at day 7; 10μM DAPT (R&D Systems # 2634/10) at day 9; and 20 ng/ml BDNF and 10 ng/ml GDNF at day 11.
+ Open protocol
+ Expand
9

Efficient Generation and Maintenance of iPSC-Derived MNs

Check if the same lab product or an alternative is used in the 5 most similar protocols
Generation and maintenance of iPSC lines is described in Lenzi et al. (2015) (link). The MN differentiation protocol has been modified from Hill et al. (2016) (link). In brief, cells were differentiated in N2B27 medium supplemented with 1 μM all-trans retinoic acid (Sigma-Aldrich) and 1 μM SAG (Merck Millipore) for 12 days in the presence of 10 μM SB431542 and 100 nM LDN-193189 (both from Miltenyi Biotec) from day 0 to 6, and 5 μM DAPT and 4 μM SU-5402 (both from Sigma-Aldrich) from day 6 to 12. Cells were sorted at day 12 using a FACSAria III (BD Biosciences) and re-plated on poly-L-ornithine-coated dishes and laminin- coated dishes (both from Sigma-Aldrich) in Neural Medium. The Hb9:GFP reporter was stably integrated in the AAVS1 locus, as described previously (Wainger et al., 2014 (link)).
+ Open protocol
+ Expand
10

Chemically Directed Differentiation of Stem Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Noggin (PeproTech, USA)
Shh (PeproTech, USA)
FGF8 (PeproTech, USA and FRCC PCM own production, Russia)
BDNF (PeproTech, USA and FRCC PCM own production, Russia)
GDNF (PeproTech, USA and FRCC PCM own production, Russia)
Purmorphamine (Stemgent, USA)
Forskolin (Stemgent, USA)
SB431542 (Stemgent, USA)
Dorsomorphin (Stemgent, USA)
ROCK inhibitor (Y27632) (Stemgent, USA)
LDN-193189 (Miltenyi biotec, USA)
Ascorbic acid (Sigma-Aldrich, USA)
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!